RE:RE:RE:But the REAL news... Past revenue isn't a true indicator of future revenue at this point, let's see if Aristotle will produce the revenue from declining Covid sales. At the high here in Ontario we are testing like 10-15 thousand a day compared to a high of 70-80 thousand. If our Covid drops at the same rate our revenue stream could be in jeopardy.
LithLover wrote: $17 million at a multiple of 5-10 would suggest a market cap of $85-170 million. Current market cap is $30 million. 3 to 5 times current share price.
So you are bashing $17 million when that would suggest a share price of of 3-5 times or $1.50-$2.50.
So you would expect much more revenue suggesting a share price well over $3.00 Gotcha. You must be constantly buying up shares.
StockscoutX wrote: Only $17+ million for 2021? I was expecting much more. Furthermore, not really new news at AGM as much of what is known is already baked into the SP. Now, it's obvious why the AGM was scheduled on june 30 a day before the canadian stock markets are closed. Also, Tripp was barely voted as a director which there will be more of the same going forward. As for the reverse split 2:1, it was a wise decision because the stock market would not have taken the news kindly to it if it was approved. As for the SP going forward, lots of sideways and maybe dip lower if nothing new comes out of StageZero.
gojotv! wrote: For "those with eyes to see and ears to hear..." as the good book says...
is that the reverse split won't happen. Even management decided against it.
And we all know that the main reason given for it was an uplisting to the NASDAQ... for which we need a higher share price.
And we all know that the main thing necessary to raise the share price is an increase in revenues...
And we all know that Rebecca called our eResearch analyst's revenue estimate of 17M for 2021 "conservative".
I'm clearly not the only one who can put together the pieces here, because the share price is rising.
GLTA!